AggregoTV - NSCLC

AggregoTV - NSCLC

Personalized Medicine, Genetic Testing Could Shape the Future of Non-Small Cell Lung Cancer

According to Dr. Nathan A.

LungART: Radiotherapy after Surgery for Patients with Non Small Cell Lung Cancer

Dr Cécile Le Péchoux talked to ecancer online about the LungART trial presented at the ESMO 2020 virtual meeting this year.

COVID-19: Management of Non-Small Cell Lung Cancer Patients During the Coronavirus Pandemic


Dr Heather Wakelee from the University of Stanford speaks to ecancer about the treatment of NSCLC patients during the COVID-19 pandemic.


Lung Cancer Immunotherapy with Dr. Leena Gandhi

Dr. Leena Gandhi leads a discussion on the latest immunotherapy for lung cancer patients.

PD-L1 Testing in Non-Small Cell Lung Carcinoma

Dr. Anja Roden discusses the role of PD-L1 interaction in the immune system, challenges with PD-L1 testing, and current PD-L1 testing in NSCLC.

PIONeeR: Understanding PD-L1 resistances in non-small cell lung cancer

Prof. Fabrice Barlesi speaks to ecancer about the ESMO 2020 virtual congress concerning a first analysis of the PIONeeR study.

Presentation of Stage III Non–Small Cell Lung Cancer


Dr. Stephen Liu presents the case of a 62-year-old man with stage III non–small cell lung cancer and provides insight into management and prognosis.

Osimertinib plus gefitinib for treatment of EGFR-mutated non-small cell lung cancer

Dr Julia Rotow talks to ecancer in an online interview for the ASCO virtual meeting 2020 about using concurrent osimertinib plus gefitinib for treating EGFR-mutated NSCLC.

ASCO 2020: Latest developments in EGFR-mutated non-small cell lung cancer

Prof Benjamin Besse and Dr Alex Spira discuss the latest developments in EGFR-mutated NSCLC.

Immunotherapy Treatments for Non-Small Cell Lung Cancer

This animation provides an overview of several immunotherapy treatments that have been approved for NSCLC.


source list reference